1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
The Lustgarten Foundation Innovation and Collaboration Program is sponsored by The Lustgarten Foundation. This program provides seed funding for innovative research with the potential to accelerate pancreatic cancer research, attracting new talent and advancing novel approaches to the field.
The foundation supports therapeutics development, including investigations into why some pancreatic cancers become resistant to KRAS inhibitors and identifying combination treatment strategies. Specific projects funded include investigating HER2 targeting in KRAS mutant pancreatic ductal adenocarcinoma and evaluating personalized treatment approaches for aggressive subtypes of pancreatic cancer using KRAS G12D inhibitors and erlotinib.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Talented scientists with historical accomplishments in cancer research now focusing on pancreatic cancer; projects focused on early diagnosis and improved therapies. Universities are eligible, as evidenced by awards to Johns Hopkins University, Columbia University, University of North Carolina, University of California, Davis, and Dana-Farber Cancer Institute. Confirm the full requirements in the official notice before applying.
The Lustgarten Foundation Innovation and Collaboration Program is funded by The Lustgarten Foundation. Verify program details on the funder's official page before applying.
This opportunity targets applicants in North Carolina and California. Check the official notice for exact location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program